about
MGL Receptor and Immunity: When the Ligand Can Make the DifferenceCells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumorsTransplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis.HPV induced triple neoplasms: a case report.Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells.Immune effects of trastuzumabHER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.Monoclonal antibodies in gynecological cancer: a critical point of view.Profiles of cancer stem cell subpopulations in cholangiocarcinomas.The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions.Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression.Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review.Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms.Optimization of the isolation and expansion method of human mediastinal-adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysatePast, present and future strategies of immunotherapy in gynecological malignancies.Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy.Suitability of human Tenon's fibroblasts as feeder cells for culturing human limbal epithelial stem cells.The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing.Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response.Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer.A standardized laboratory and surgical method for in vitro culture isolation and expansion of primary human Tenon's fibroblasts.A comparative analysis of serum and serum-free media for generation of clinical grade DCs.Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder.Cellular Adaptive Immune System Plays a Crucial Role in Trastuzumab Clinical EfficacyTargeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activationTumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic CellsMAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapyCancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factorsDeath from metastatic donor-derived ovarian cancer in a male kidney transplant recipientInteraction between Treg cells and angiogenesis: a dark double track
P50
Q26769924-06EBD664-148F-442B-BB51-F15651417171Q28247911-99BD4F6F-02A8-4C64-B612-1A2763664DD5Q34707880-8A27ECF8-C77E-4DE1-A9DF-785A429183C2Q34995034-1F8136D1-D124-4DE5-B7C6-7B0CE49B0093Q35024484-0F90A5D5-CBE6-4D53-8932-2C615EA5E135Q35057976-396580B6-6122-42BE-9492-CF991DB1F389Q35556207-0D335403-1447-4684-ABFC-DD894E08C7F2Q35659915-90E73E60-39A4-4CC5-913A-6829B7C12BB2Q35669078-89D0F750-7545-4116-9F5D-18F1FD639EFBQ35684064-2EE33496-0277-41DC-8942-8F922D89163EQ37294314-B98DB2E8-7FDC-43AA-A5DE-3E7C5A6AEE59Q37638386-DD760B3A-AA6E-473F-A44C-6235B6A22670Q37953105-52D6E5AA-02B6-4EB3-95A0-5B028C4A91CAQ39301259-551F883B-B618-45DF-A3F5-EE00C837E682Q39560771-18B21900-A952-43C2-9218-09700EC5127AQ39788533-7AFCB911-DF5E-4E74-9385-61EA98D4CB78Q42816881-E663B1C8-BEAC-4345-AFB7-9AF90B0AABF0Q43551307-73B85DA1-8D70-4D1A-9255-274C9387978FQ44839641-8B53F8CD-FE20-4BC4-9F18-EB0F69B528D8Q46578884-D00952DD-8227-4697-A33B-341E2E06F6EDQ46579517-FAA36BB4-95E4-4A62-A8B2-780570624385Q50243704-B9BD8A05-AD6D-4A81-B66A-A1C37187AF7DQ50971466-21DF8C96-1C56-424C-A608-F6B32CD6A1D5Q53066287-3A98CA08-3BC9-4F94-9CC1-3C428DAE4676Q56989099-1735DB69-A294-479A-80D4-B624D289E2A4Q57195316-C125A7C6-A189-4ABC-B178-D3A1684796F5Q57195392-A29C2BC9-9D74-480F-A1F2-DC11102257F8Q80425315-4E4E90B0-E803-4708-8165-2181A995EE77Q81470581-D24C5041-C75D-4794-9D2C-34A5B894FCB3Q83784065-58B05680-2DD3-4E32-A5D3-AA8046A89F56Q85327756-2CB9010E-A66F-477B-93D8-362E9FDBB79D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
C Napoletano
@ast
C Napoletano
@en
C Napoletano
@es
C Napoletano
@nl
type
label
C Napoletano
@ast
C Napoletano
@en
C Napoletano
@es
C Napoletano
@nl
prefLabel
C Napoletano
@ast
C Napoletano
@en
C Napoletano
@es
C Napoletano
@nl
P106
P31
P496
0000-0001-5449-5430